Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial.

Gulliford SL, Miah AB, Brennan S, McQuaid D, Clark CH, Partridge M, Harrington KJ, Morden JP, Hall E, Nutting CM.

Radiother Oncol. 2012 Aug;104(2):205-12. doi: 10.1016/j.radonc.2012.07.005. Epub 2012 Aug 8.

PMID:
22883107
2.

Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A'Hern RP, Sydenham MA, Emson M, Hall E; PARSPORT trial management group.

Lancet Oncol. 2011 Feb;12(2):127-36. doi: 10.1016/S1470-2045(10)70290-4. Epub 2011 Jan 12.

3.

Dosimetry audit for a multi-centre IMRT head and neck trial.

Clark CH, Hansen VN, Chantler H, Edwards C, James HV, Webster G, Miles EA, Guerrero Urbano MT, Bhide SA, Bidmead AM, Nutting CM; PARSPORT Trial Management Group.

Radiother Oncol. 2009 Oct;93(1):102-8. doi: 10.1016/j.radonc.2009.04.025.

PMID:
19596158
4.

Compensator-based intensity-modulated radiotherapy in head and neck cancer: our experience in achieving dosimetric parameters and their clinical correlation.

Nangia S, Chufal KS, Arivazhagan V, Srinivas P, Tyagi A, Ghosh D.

Clin Oncol (R Coll Radiol). 2006 Aug;18(6):485-92.

PMID:
16909973
5.

Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines.

Guerrero Urbano MT, Clark CH, Kong C, Miles E, Dearnaley DP, Harrington KJ, Nutting CM, PARSPORT Trial Management Group.

Clin Oncol (R Coll Radiol). 2007 Oct;19(8):604-13. Epub 2007 Aug 13.

PMID:
17706404
6.

Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.

Anand AK, Jain J, Negi PS, Chaudhoory AR, Sinha SN, Choudhury PS, Kumar R, Munjal RK.

Clin Oncol (R Coll Radiol). 2006 Aug;18(6):497-504.

PMID:
16909975
7.

Accuracy requirements for head and neck intensity-modulated radiation therapy based on observed dose response of the major salivary glands.

Kapanen M, Collan J, Saarilahti K, Heikkonen J, Kairemo K, Tenhunen M.

Radiother Oncol. 2009 Oct;93(1):109-14. doi: 10.1016/j.radonc.2009.04.023. Epub 2009 May 10.

PMID:
19435641
8.

Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.

Lauve A, Morris M, Schmidt-Ullrich R, Wu Q, Mohan R, Abayomi O, Buck D, Holdford D, Dawson K, Dinardo L, Reiter E.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):374-87.

PMID:
15380569
9.

Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.

Chen AM, Daly ME, Farwell DG, Vazquez E, Courquin J, Lau DH, Purdy JA.

JAMA Otolaryngol Head Neck Surg. 2014 Feb;140(2):129-33. doi: 10.1001/jamaoto.2013.5988.

PMID:
24337483
11.

Comparing 3DCRT and inversely optimized IMRT planning for head and neck cancer: equivalence between step-and-shoot and sliding window techniques.

Longobardi B, De Martin E, Fiorino C, Dell'oca I, Broggi S, Cattaneo GM, Calandrino R.

Radiother Oncol. 2005 Nov;77(2):148-56. Epub 2005 Nov 2.

PMID:
16260056
12.

Left-sided breast cancer radiotherapy with and without breath-hold: does IMRT reduce the cardiac dose even further?

Mast ME, van Kempen-Harteveld L, Heijenbrok MW, Kalidien Y, Rozema H, Jansen WP, Petoukhova AL, Struikmans H.

Radiother Oncol. 2013 Aug;108(2):248-53. doi: 10.1016/j.radonc.2013.07.017. Epub 2013 Sep 14.

PMID:
24044804
13.

Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain.

Powell C, Schick U, Morden JP, Gulliford SL, Miah AB, Bhide S, Newbold K, Harrington KJ, Nutting CM.

Radiother Oncol. 2014 Mar;110(3):416-21. doi: 10.1016/j.radonc.2013.06.042. Epub 2013 Aug 13.

PMID:
23953411
14.

Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.

Hansen EK, Bucci MK, Quivey JM, Weinberg V, Xia P.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):355-62. Epub 2005 Oct 26.

PMID:
16256277
15.

Parotid gland-recovery after radiotherapy in the head and neck region--36 months follow-up of a prospective clinical study.

Hey J, Setz J, Gerlach R, Janich M, Hildebrandt G, Vordermark D, Gernhardt CR, Kuhnt T.

Radiat Oncol. 2011 Sep 27;6:125. doi: 10.1186/1748-717X-6-125.

16.
17.

High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome.

Bi XW, Li YX, Fang H, Jin J, Wang WH, Wang SL, Liu YP, Song YW, Ren H, Dai JR.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1086-93. doi: 10.1016/j.ijrobp.2013.08.040. Epub 2013 Oct 10.

PMID:
24120822
18.

3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing.

Wendt TG, Abbasi-Senger N, Salz H, Pinquart I, Koscielny S, Przetak SM, Wiezorek T.

Radiat Oncol. 2006 Jun 21;1:18.

19.

Volumetric intensity-modulated arc therapy vs conventional intensity-modulated radiation therapy in nasopharyngeal carcinoma: a dosimetric study.

White P, Chan KC, Cheng KW, Chan KY, Chau MC.

J Radiat Res. 2013 May;54(3):532-45. doi: 10.1093/jrr/rrs111. Epub 2012 Nov 27.

20.

Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.

Vergeer MR, Doornaert PA, Rietveld DH, Leemans CR, Slotman BJ, Langendijk JA.

Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):1-8. doi: 10.1016/j.ijrobp.2008.07.059. Epub 2008 Dec 26.

PMID:
19111400
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk